BONELLI, LORENZA ISABELLA
 Distribuzione geografica
Continente #
NA - Nord America 771
EU - Europa 443
AS - Asia 260
Continente sconosciuto - Info sul continente non disponibili 1
SA - Sud America 1
Totale 1.476
Nazione #
US - Stati Uniti d'America 763
CN - Cina 168
IE - Irlanda 76
SE - Svezia 75
UA - Ucraina 61
DE - Germania 48
FI - Finlandia 47
KR - Corea 44
FR - Francia 34
PL - Polonia 26
IT - Italia 25
SG - Singapore 23
GB - Regno Unito 15
AT - Austria 13
VN - Vietnam 9
BE - Belgio 8
CA - Canada 5
GR - Grecia 5
TH - Thailandia 5
MX - Messico 3
NL - Olanda 3
RS - Serbia 3
JP - Giappone 2
PH - Filippine 2
SA - Arabia Saudita 2
UZ - Uzbekistan 2
CO - Colombia 1
DK - Danimarca 1
ES - Italia 1
HK - Hong Kong 1
IN - India 1
IR - Iran 1
RO - Romania 1
RU - Federazione Russa 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 1.476
Città #
Chandler 208
Beijing 143
Dublin 76
Ann Arbor 49
Jacksonville 37
Dearborn 35
Ashburn 27
Warsaw 26
Nyköping 25
Princeton 25
Wilmington 22
Houston 21
Villeurbanne 21
Boston 19
Medford 16
Singapore 14
Vienna 13
New York 12
San Mateo 11
Woodbridge 11
Fremont 10
Milan 9
Boardman 8
Brussels 8
Redwood City 7
Dong Ket 6
Kunming 6
Norwalk 6
Seattle 6
Munich 5
Hefei 4
Pisa 4
Washington 4
Belgrade 3
Falls Church 3
Shrewsbury 3
Toronto 3
Verona 3
Edinburgh 2
Fairfield 2
Fuzhou 2
Guangzhou 2
Jinan 2
Lachine 2
Mountain View 2
Nanjing 2
Romainville 2
Silver Spring 2
Tokyo 2
Amsterdam 1
Ardabil 1
Atlanta 1
Bogotá 1
Bologna 1
Buffalo 1
Cambridge 1
Changchun 1
Chicago 1
Cuauhtémoc 1
El Paso 1
Forlì 1
Helsinki 1
Hong Kong 1
Huddersfield 1
Leiden 1
Los Angeles 1
Madrid 1
Nanchang 1
Nuremberg 1
Pristina 1
Pune 1
Saint Petersburg 1
Shanghai 1
Shenyang 1
St Louis 1
Stockholm 1
Sumter 1
Swansea 1
Tappahannock 1
Thessaloníki 1
Torino 1
Velletri 1
Viadana 1
Wayne 1
Xian 1
Totale 967
Nome #
Neuroendocrine effects of citalopram, a selective serotonine re-uptake inhibitor, during life span in humans 133
EFFECTS OF GNRH-RECEPTOR BLOCKADE ON GONADAL AXIS IN WOMEN WITH FUNCTIONAL HYPOTHALAMIC AMENORRHEA 94
HYPERCORTISOLISM DUE TO CUSHING’S DISEASE IS ASSOCIATED TO DERANGED GHRELIN SECRETION AND ACTION 93
CONVENTIONAL GLUCOCORTICOID REPLACEMENT THERAPY IN PATIENTS WITH ADDISON’S DISEASE: EFFECT ON METABOLIC AND BONE PARAMETERS 75
Ghrelin, hypothalamus-pituitary-adrenal (HPA) axis and Cushing's syndrome 73
HORMONAL, METABOLIC AND BONE EVALUATION IN A SERIES OF ADRENAL INCIDENTALOMAS 73
EVALUATION OF BASAL AND STIMULATED HYPOTHALAMUS-PITUITARY-ADRENAL (HPA) ACTIVITY IN PRIMARY HYPERALDOSTERONISM 71
PATIENTS WITH AUTOIMMUNE DISEASES SHOWED ENHANCED BASAL AND STIMULATED CORTICOTROPH SECRETION 68
Neuroregulation of the hypothalamus-pituitary-adrenal (Hpa) axis in humans: effects of Gaba-, mineralcortoid-, and gh-secretagogue-receptor modulation 65
Hypothalamus-pituitary-adrenal hyperactivity in human aging is partially refractory to stimulation by mineralocorticoid receptor blockade 64
COMPARISON BETWEEN ITT, METYRAPONE AND ACTH STIMULATION WITH HIGH, LOW AND VERY LOW DOSES FOR DIAGNOSIS OF SECONDARY HYPOADRENALISM 64
NEUROENDOCRINE EFFECTS OF CITALOPRAM, A SELECTIVE SEROTONIN RE-UPTAKE INHIBITOR (SSRI), DURING LIFESPAN IN HUMANS 63
Hypothalamus-pituitary-adrenal axis evaluation in patients with hypothalamo-pituitary disorders: comparison of different provocative test 61
WRIST ACTIGRAPHY DOES NOT REVEAL SLEEP DISTURBANCES IN PATIENTS WITH ADDISON’S DISEASE UNDER CONVENTIONAL GLUCOCORTICOID REPLACEMENT THERAPY 61
COMPARISON BETWEEN CORTISOL AND DEXAMETHASONE NEGATIVE FEEDBACK ACTION IN HUMANS 59
Growth hormone treatment in human ageing: benefits and risks 58
PATIENTS WITH AUTOIMMUNE DISEASES SHOW IMPAIRED ADRENAL SENSITIVITY TO ACTH 1-24 BUT ENHANCED BASAL AND STIMULATED CORTICOTROPH SECRETION 58
EFFECTS OF GHRELIN ON HYPOTHALAMO-PITUITARY-ADRENAL AXIS IN PATIENTS WITH CUSHING’S SYNDROME OF DIFFERENT ETIOLOGY 57
Corticotrope hypersecretion coupled with cortisol hypo-responsiveness to stimuli is present in patients with autoimmune endocrine disease: evidence for subclinical primary hypoadrenalism? 57
EFFECTS OF CORTISTATIN-17 AND SOMATOSTATIN-14 ON ACTH AND CORTISOL HYPERSECRETION IN PATIENTS WITH CUSHING’S DISEASE 57
HYPOTHALAMO-PITUITARY-ADRENAL HYPERACTIVITY IN HUMAN AGING IS FURTHER ENHANCED BY MINERALCORTICOID ANTAGONISTS 52
Primary hyperaldosteronism is associated with derangement in the regulation of the hypothalamus-pituitary-adrenal axis in humans 45
WRIST ACTIGRAPHY REVEALS SLEEP DISTURBANCES IN PATIENTS WITH CUSHING’S DISEASE 36
Totale 1.537
Categoria #
all - tutte 4.893
article - articoli 0
book - libri 0
conference - conferenze 3.110
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 8.003


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020171 1 2 8 21 9 35 39 8 7 19 20 2
2020/2021167 31 13 4 6 35 4 15 7 12 13 13 14
2021/2022198 1 5 5 12 4 8 27 8 10 11 50 57
2022/2023430 49 53 10 50 28 113 26 29 35 7 21 9
2023/2024134 24 33 6 7 8 24 1 3 0 1 8 19
Totale 1.537